Clinical Trial Update: Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and tolerability of Lagricel Ofteno Multi-dose Ophthalmic Solution for dry eye has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Lagricel Ofteno

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Dry Eye | Phase 1 | Status: COMPLETED | Results posted: 2021-05-03